REGN - Regeneron Pharmaceuticals Inc. (REGN) Management presents at Jefferies 2024 Global Healthcare Conference (Transcript)
2024-06-05 12:43:09 ET
Regeneron Pharmaceuticals, Inc. (REGN)
Jefferies 2024 Global Healthcare Conference
June 5, 2024 8:30 AM ET
Company Participants
Mark Hudson - Investor Relations
Israel Lowy - SVP of Translational & Clinical Sciences, Oncology
Andres Sirulnik - SVP of Translational & Clinical Sciences, Hematology
Conference Call Participants
Akash Tewari - Jefferies
Presentation
Akash Tewari
All righty. Good morning, everyone. Day 1 of public companies for Jefferies Healthcare Conference here in beautiful Times Square. I'm not going to hear anything else. It's beautiful. For those who don't know me, my name is Akash Tewari. I cover pharma and biotech companies here at Jefferies. And I have the pleasure of hosting the Pride of Tarrytown, Regeneron. And this is actually quite unique because we have leaders both in the hematology and oncology division areas where I think investors definitely should be paying a lot more attention to at Regeneron.
I'm going to hand it off to Mark, who's going to give some introductory remarks and also introduce the execs who are joining us today. Thank you....
Regeneron Pharmaceuticals, Inc. (REGN) Management presents at Jefferies 2024 Global Healthcare Conference (Transcript)